Clinical Trial Update: Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated a taurolidine-containing urokinase solution to prevent dialysis catheter malfunction and infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Taurolidine-containing urokinase (taurolidine + urokinase)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Patency, Infection | Phase 3 | Status: COMPLETED